Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases

A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

clinical research
New Tracer Gives Clear Picture of Alzheimer’s and Other Dementias
New Tracer Gives Clear Picture of Alzheimer’s and Other Dementias
Ian Le Guillou | Oct 29, 2020
An imaging agent reveals aggregated tau protein in the brain during PET scans and could improve the diagnosis of neurodegenerative diseases, particularly tauopathies.
Eli Lilly Halts Antibody Trial in Hospitalized COVID-19 Patients
Eli Lilly Halts Antibody Trial in Hospitalized COVID-19 Patients
Ashley Yeager | Oct 27, 2020
Recent data show that the drug bamlanivimab, also known as LY-CoV555, does not appear to help those with severe cases of COVID-19, but trials continue for milder cases.
Mexican Senate Votes to Cut Research Funding, Disaster Relief
Mexican Senate Votes to Cut Research Funding, Disaster Relief
Lisa Winter | Oct 22, 2020
Government leaders claim the reductions are necessary to free up assets to deal with COVID-19 and address corruption in research.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
What We Know About Donald Trump’s COVID-19 Treatment Plan
What We Know About Donald Trump’s COVID-19 Treatment Plan
Lisa Winter | Oct 5, 2020
The President was hospitalized on Friday evening and has been receiving an aggressive treatment of experimental and standard drugs.
Timothy Ray Brown, First Person to Be Cured of HIV, Dies
Timothy Ray Brown, First Person to Be Cured of HIV, Dies
Kerry Grens | Sep 30, 2020
The AIDS activist, also known as the Berlin patient, represented optimism that scientists could find a way to beat HIV.
<em>The Lancet&nbsp;</em>Alters Editorial Practices After Surgisphere Scandal
The Lancet Alters Editorial Practices After Surgisphere Scandal
Catherine Offord | Sep 22, 2020
The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
Antibody-Based Drug May Reduce COVID-19 Hospitalizations: Study
Antibody-Based Drug May Reduce COVID-19 Hospitalizations: Study
Lisa Winter | Sep 17, 2020
Eli Lilly reports a 72 percent reduction in hospitalization risk among patients who received its monoclonal antibody compared to those who received a placebo.
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.